Insights

Innovative Therapeutics ProKidney's focus on cellular therapy for chronic kidney disease positions it as a leader in regenerative medicine, offering advanced treatment options that could appeal to healthcare providers seeking cutting-edge solutions for high-risk diabetic patients.

Late-Stage Development With rilparencel in Phase 2 and Phase 3 trials and receiving FDA's RMAT designation, ProKidney presents opportunities to partner or supply complementary technologies for clinical trial support, manufacturing, or regulatory consulting.

Expansion & Investment Recent $22.5 million funding and local hiring surge indicate strong growth momentum, creating potential sales opportunities in laboratory equipment, office infrastructure, and talent acquisition solutions tailored for expanding biotech firms.

Market Engagement ProKidney actively participates in major industry conferences such as ASN Kidney Week and J.P. Morgan Healthcare Conference, providing channels for targeted business collaborations, strategic partnerships, and educational outreach to key decision-makers.

Industry Positioning Operating in a biotech sector with global giants like Boehringer Ingelheim and Pfizer, ProKidney's innovative stance presents prospects for niche technology licensing, joint ventures, or specialized supplier relationships to accelerate product development and market entry.

ProKidney Corp. Tech Stack

ProKidney Corp. uses 8 technology products and services including BootstrapCDN, Open Graph, oEmbed, and more. Explore ProKidney Corp.'s tech stack below.

BootstrapCDN

Content Delivery Network

Open Graph

Content Management System

oEmbed

Dev Tools

LabVantage

Health Platform

Flickity

Javascript Libraries

UPS

Logistics

Online Community Software

Adobe Creative Suite

Visualisation Software

ProKidney Corp. Email Formats	Example	Percentage
First.Last@prokidney.com	John.Doe@prokidney.com	100%

ProKidney Corp. Email Formats

Example

Percentage

First.Last@prokidney.com

John.Doe@prokidney.com

100%

Frequently Asked Questions

Where is ProKidney Corp.'s headquarters located?

ProKidney Corp.'s main headquarters is located at 2000 Frontis Plaza Boulevard 250 Winston-salem, North Carolina 27103 United States. The company has employees across 2 continents, including North AmericaEurope.

What is ProKidney Corp.'s official website and social media links?

ProKidney Corp.'s official website is prokidney.com and has social profiles on LinkedIn.

What is ProKidney Corp.'s SIC code NAICS code?

ProKidney Corp.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ProKidney Corp. have currently?

As of April 2026, ProKidney Corp. has approximately 218 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: B. C.Cfo: J. C.Chief People Officer: C. P.. Explore ProKidney Corp.'s employee directory with LeadIQ.

What industry does ProKidney Corp. belong to?

ProKidney Corp. operates in the Biotechnology Research industry.

What technology does ProKidney Corp. use?

ProKidney Corp.'s tech stack includes BootstrapCDNOpen GraphoEmbedLabVantageFlickityUPSLinkedInAdobe Creative Suite.

What is ProKidney Corp.'s email format?

ProKidney Corp.'s email format typically follows the pattern of First.Last@prokidney.com. Find more ProKidney Corp. email formats with LeadIQ.

ProKidney Corp.

Q: What is ProKidney Corp.'s official website and social media links?

ProKidney Corp.'s official website is prokidney.com. ProKidney Corp. has social profiles on LinkedIn.

Q: How many employees does ProKidney Corp. have currently?

ProKidney Corp. has approximately 218 employees.

Q: What technology does ProKidney Corp. use?

ProKidney Corp.'s tech stack includes LabVantage, React, Yoast SEO, SAS Office Analytics, Google Tag Manager.

Q: What is ProKidney Corp.'s NAICS code?

ProKidney Corp.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchNorth Carolina, United States201-500 Employees

ProKidney, a pioneer in the treatment of chronic kidney disease through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, rilparencel (also known as REACT®), is a first-in-class, patented, proprietary autologous cellular therapy being evaluated in Phase 2 and Phase 3 studies for its potential to preserve kidney function in diabetic patients at high risk of kidney failure. Rilparencel has received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA. For more information, please visit www.prokidney.com.

Insights

Similar companies to ProKidney Corp.

Boehringer Ingelheim

sanofi

Vertex Pharmaceuticals

Moderna

Pfizer

AstraZeneca

Novartis Institutes for BioMedical Research (NIBR)

ProKidney Corp. Tech Stack

Media & News

ProKidney Corp is developing rilparencel for patients with Stage 3b/4 CKD and diabetes.

ProKidney Corp is developing novel cell therapy.

ProKidney Corp hired Greg Madison as Chief Commercial Officer on Mar 25th '26.

ProKidney Corp attends event 44th Annual J.P. Morgan Healthcare Conference.

ProKidney Corp expands offices in Winston-Salem, North Carolina, United States, Northern America, Americas.

ProKidney Corp increases headcount by 50.

ProKidney Corp attends event American Society of Nephrology Kidney Week 2025.

ProKidney Corp.'s Email Address Formats